Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

PHASE3CompletedINTERVENTIONAL
Enrollment

435

Participants

Timeline

Start Date

April 29, 2021

Primary Completion Date

July 21, 2023

Study Completion Date

July 21, 2023

Conditions
Acute Respiratory Viral Infection
Interventions
DRUG

Raphamin

"Oral administration - not with food. Keep the tablet in the mouth until it is completely dissolved.~On the 1st day of treatment, 8 tablets are taken according to the following scheme: 1 tablet every 30 minutes in the first 2 hours (a total of 5 tablets in 2 hours), then during the same day, take another 1 tablet 3 times at regular intervals. On the 2nd day and then take 1 tablet 3 times a day. The duration of treatment is 5 days."

DRUG

Placebo

Oral administration - not with food. Placebo using Raphamin scheme.

Trial Locations (29)

105554

"Llc Olla-Med", Moscow

117997

Russian National Research Medical University named after N.I. Pirogov, Moscow

119049

Morozovskaya Children's City Clinical Hospital of the Moscow Department of Health, Moscow

119435

Federal Scientific and Clinical Center for Physical and Chemical Medicine of the Federal Medical and Biological Agency, Moscow

129515

"Llc Diagnostics and Vaccines", Moscow

150000

Yaroslavl State Medical University/Department of Pediatrics IPGE, Yaroslavl

Yaroslavl State Medical University/Department of Pediatrics № 2, Yaroslavl

150030

Clinical Hospital # 2, Yaroslavl

191144

Children's city polyclinic # 44, Saint Petersburg

194156

"LLC Energy of health", Saint Petersburg

196191

Children's city polyclinic # 35, Saint Petersburg

197376

Research Institute of Influenza named after A.A. Smorodintsev, Saint Petersburg

214019

Smolensk State Medical University, Smolensk

344011

"Clinical and diagnostic center Health of the city of Rostov-on-Don", Rostov-on-Don

344019

Children's City Hospital #1 of Rostov-on-Don city, Rostov-on-Don

344022

Rostov State Medical University, Rostov-on-Don

350015

Specialized Clinical Hospital for Infectious Diseases, Krasnodar

390026

Ryazan State Medical University named after academician I.P. Pavlov, Ryazan

400131

Volgograd State Medical University/Department of Pediatrics and Neonatology, Volgograd

410005

"LLC DNA Research Center", Saratov

420012

Kazan State Medical University, Kazan'

420097

"Llc Medlight", Kazan'

430005

National Research Mordovian State University named after N.P. Ogarev, Saransk

443079

Samara Regional Children's Clinical Hospital named after N.N. Ivanova, Samara

450008

Bashkir State Medical University/Department of Outpatient and Emergency Pediatrics, Ufa

614066

City Children's Clinical Polyclinic # 5, Perm

614070

"LLC Professorial Clinic", Perm

620144

"LLC European Medical Center UMMC-Health", Yekaterinburg

630091

Novosibirsk State Medical University, Novosibirsk

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT04918771 - Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old | Biotech Hunter | Biotech Hunter